The Global Neuromodulation Market is estimated to be valued at USD 31.87 Billion by 2035 at an exponential growth of 12.35% ...

We anticipate LivaNova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...

Looking for the latest stock opportunities in August 2025? Click to read these top stock picks to consider adding to your portfolio now.

Medtronic's separation of its Medtronic Diabetes unit into a publicly traded company named MiniMed will be a new beginning ...